Inactive Instrument
Numinus Wellness Inc. Stock Toronto S.E.
Stocks
NUMI
CA67054W1032
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 19.82M 14.22M 12.3M 11.49M 10.54M 1.35B 20.13M 135M 52.89M 678M 53.39M 52.22M 2.24B | P/E 2023 |
-1.72x | P/E 2024 | -0.48x |
|---|---|---|---|---|---|
| Enterprise Value | 19.89M 14.27M 12.34M 11.53M 10.58M 1.36B 20.21M 135M 53.09M 681M 53.59M 52.42M 2.25B | EV / Sales 2023 |
2.21x | EV / Sales 2024 | 2.48x |
| Free-Float |
98.26% | Yield 2023 * |
-
| Yield 2024 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Tan
CEO | Chief Executive Officer | - | 2025-01-22 |
Kelvin Yang
DFI | Director of Finance/CFO | - | 2025-02-17 |
Paul Thielking
CTO | Chief Tech/Sci/R&D Officer | - | 2022-06-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Payton Nyquvest
CHM | Chairman | - | 1962-06-25 |
Michael Tan
BRD | Director/Board Member | - | 2020-05-14 |
Larry Timlick
BRD | Director/Board Member | 69 | 2019-01-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +11.11% | - | - | 11.34M | ||
| +0.99% | +1.78% | +5.07% | +16.49% | 49.47B | ||
| +3.71% | +9.40% | +486.14% | +579.98% | 43.61B | ||
| +5.60% | +10.21% | +20.85% | +81.78% | 39.6B | ||
| +2.70% | +1.57% | +32.71% | +9.07% | 39.29B | ||
| +2.21% | +6.75% | +20.20% | +54.40% | 32.43B | ||
| +2.23% | +4.71% | - | - | 16.84B | ||
| +0.97% | +2.35% | +35.99% | +124.45% | 16.49B | ||
| -0.11% | +2.41% | +5.03% | +20.47% | 14.01B | ||
| +0.75% | +15.04% | +79.84% | +29.70% | 12.77B | ||
| Average | +1.90% | +6.32% | +85.73% | +114.54% | 29.39B | |
| Weighted average by Cap. | +2.54% | +6.10% | +104.59% | +138.04% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 23.18M 16.63M 14.39M 13.43M 12.32M 1.58B 23.55M 158M 61.87M 793M 62.46M 61.09M 2.62B | 4.17M 2.99M 2.59M 2.42M 2.22M 285M 4.23M 28.34M 11.13M 143M 11.23M 10.99M 472M |
| Net income | -30.26M -21.71M -18.78M -17.54M -16.09M -2.07B -30.74M -206M -80.75M -1.04B -81.52M -79.74M -3.42B | -19.64M -14.09M -12.19M -11.38M -10.44M -1.34B -19.95M -134M -52.42M -672M -52.92M -51.77M -2.22B |
| Net Debt | -1.38M -990K -857K -800K -734K -94.24M -1.4M -9.38M -3.68M -47.24M -3.72M -3.64M -156M | 74.32K 53.32K 46.12K 43.07K 39.51K 5.07M 75.5K 505K 198K 2.54M 200K 196K 8.41M |
Employees
-
















